Cancers · 2022 · 11 citations · 32 references
MedicineGeneticsUrologyCancer GeneticsGenitourinary OncologyMedical GeneticsBiomarkers In Genitourinary CancerBiomarkers In Urologic OncologyBladder CancerCancer Molecular DiagnosticsNext-generation Sequencing In OncologyUrologic Cancer DiagnosisCohort Study InvestigationDiagnostic Assay DevelopmentDiagnostic Assay ValidationGene Mutation DetectionMutationPoint Mutation ScreeningUpper Tract Urothelial Carcinoma BiomarkersUrine-based Cancer Detection
Background: To improve the selection of patients for ureteroscopy, avoid excessive testing and reduce costs, we aimed to develop and validate a diagnostic urine assay for upper tract urinary carcinoma (UTUC). Methods: In this cohort study we recruited 402 patients from six Hunan hospitals who underwent ureteroscopy for hematuria, including 95 patients with UTUC and 307 patients with non-UTUC findings. Midstream morning urine samples were collected before ureteroscopy and surgery. DNA was extracted and qPCR was used to analyze mutations in TERT and FGFR3 and the methylation of NRN1. In the training set, the random forest algorithm was used to build an optimal panel. Lastly, the Beijing cohort (n = 76) was used to validate the panel. Results: The panel combining the methylation with mutation markers led to an AUC of 0.958 (95% CI: 0.933–0.975) with a sensitivity of 91.58% and a specificity of 94.79%. The panel presented a favorable diagnostic value for UTUC vs. other malignant tumors (AUC = 0.920) and UTUC vs. benign disease (AUC = 0.975). Furthermore, combining the panel with age revealed satisfactory results, with 93.68% sensitivity, 94.44% specificity, AUC = 0.970 and NPV = 98.6%. In the external validation process, the model showed an AUC of 0.971, a sensitivity of 95.83% and a specificity of 92.31, respectively. Conclusions: A novel diagnostic model for analyzing hematuria patients for the risk of UTUC was developed, which could lead to a reduction in the need for invasive examinations. Combining NRN1 methylation and gene mutation (FGFR3 and TERT) with age resulted in a validated accurate prediction model.
32
Patrick Killela, Zachary J. Reitman, Yuchen Jiao et al. · Proceedings of the National Academy of Sciences · 2013 · 1.4K citations · Full text
Morgan Rouprêt, Marko Babjuk, Éva Compérat et al. · European Urology · 2015 · 1.3K citations
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen, Rajat Singhania, Gordon Fehringer et al. · Nature · 2018 · 1K citations · Full text